Recently, all series of Rui Bang's digital solutions and core innovative self-developed achievements have appeared again at the China International Medical Equipment Exhibition (China-Hospeq 2024) and the technical exchange conference, discussing global health and high-quality development. In 2024, August 14th, Shenzhen / US News Agency /

As a renewed strength for high-quality development, Rui Bang's breakthrough digital innovation achievements are accelerating to emerge. With cutting-edge product ecology and strong innovation capabilities, it is providing a Chinese solution for global health and high-quality development.

Focus on new quality forces
Digital-driven domestic substitution enters the fast lane

Based on high-standard innovative concept, Rui Bang is constantly seizing the commanding heights of key technologies and accelerating domestic substitution progress. Rui Bang always insists on independent research and development of core technology, realizing a wide range of layout in the field of high-end parameter technology of monitoring, and continuously promoting the import substitution of most core technologies in the monitoring field, gradually establishing a significant competitive advantage in the monitoring market.

IV series patient monitor, a new generation plug-in monitor, which recently listed in China, provides richer parameter applications and department configuration schemes for the emergency and critically ill fields, and integrates many industry-leading monitoring technologies.

It is in line with international advanced level, self-developed advanced parameter configuration of muscle relaxation monitoring, electroencephalogram monitoring and other advanced modules, breaking the international monopoly, and innovating technologies such as continuous cardiac output (CCO) monitoring. In addition, the applications of new functions such as dual pulse oximetry, CCHD, sepsis, convenient and comfortable interactive experience, humanized design language, and in-depth information interaction function comprehensively upgrade the clinical experience and workflow of critical illness.

The flagship product F15 series fetal/maternal monitor continues RuiBang's leading care concept in the fetal monitor field. Based on the difficulties of traditional monitoring technology, RuiBang has independently developed the core patented technology of fetal electrocardiographic monitoring "IQ (orthogonal) demodulation innovation technology", which innovatively solves the theoretical defects such as "doubling" and "halving" of fetal monitoring, as well as misjudging maternal heart rate, driving the reform of fetal monitoring equipment and greatly improving the accuracy of fetal monitoring during childbirth.

This technological achievement has been highly recognized by clinical experts at home and abroad, and has continued to settle in domestic top three hospitals and high-end medical institutions in Europe and the United States. It won the title of national manufacturing single champion product in 2021.

Acclarix AX8, a brand-new upgraded portable full-digital color ultrasound diagnostic system tailored for point-of-care (POC) field, i20 blood gas blood oxygen electrolyte analyzer, which opens the blood gas detection 2.0 era, SEMIP automatic measurement and analysis algorithm for electrocardiography, SE-1200 Pro digital electrocardiograph with portability, intelligence and networking as its core, iX series patient monitor which innovatively creates new methods of blood pressure monitoring in the industry, all these works have high light appearance.

In addition, RuiBang's smart health business is also strongly laid out, integrating hardware and software, and enabling hospital upgrades with informationization. The RuiBang intelligent health product ecology adopts the information product strategic layout of "IoT-interconnection-interoperability-sharing", fully connecting equipment, data, system, and platform to achieve full-structured data collection, processing, and application.

At the interconnection layer, clinical informationization solutions such as intelligent emergency, intelligent obstetrics, intelligent child care, and intelligent heart health cover the entire process of emergency department, obstetrics and gynecology, cardiology and other businesses. At the interconnect layer, medical technology informationization solutions represented by intelligent heart network, intelligent monitoring, intelligent fetal monitoring, and intelligent electrophysiology, etc., together with RuiBang's high-performance acquisition equipment and core algorithms, help hospital and medical alliance informationization to build high-quality. RuiBang Cloud+AI, as the top-level architecture of the smart health product ecology, continues to promote the intelligent, automatic, standardized, and standardized level of medical informationization projects.

Creating quality benchmarks
From the "Healthy Silk Road" to the global health ecosystem

The "Healthy Silk Road" is moving towards the high-quality development stage, and RuiBang's global circle of friends is also deepening. From the establishment of subsidiary companies in countries with high admission thresholds such as the United States, Germany, and the United Kingdom, to the construction of three overseas sales subsidiaries along the "Belt and Road" in Kenya, Peru, and Thailand in the past two years, RuiBang has formed a global localized closed-loop ecological chain that integrates production, sales, and services, and a strategic layout of regional operating centers in North America, Latin America, Africa, and other regions.

Establishing a foothold on the global stage and achieving international quality standards is an important milestone. As early as 2001, Edan passed the ISO13485 quality management system certification and has always insisted on the participation of all employees in quality management. Quality control for research and development, procurement, production processes, and after-sales services is included in the quality system throughout the product lifecycle. Reliable design was introduced, and EMC laboratories were established, among other steps, to ensure quality protection for products throughout the entire process and for the entire range, enhancing Edan's competitive advantage in the global medical device supply chain.

Currently, Edan's quality system has been audited by the Medical Device Single Audit Program (MDSAP) jointly promoted by the United States, Canada, Australia, Brazil, and Japan. The products have obtained certification for product access to target markets such as China, the United States, and the European Union. Edan's products are of high-quality standard globally, laying a solid foundation for developing a localized presence around the world.

Under high-quality standards, Edan's products and services cover more than 170 countries and regions worldwide. It is worth mentioning that Edan's fetal/maternal monitoring equipment has entered more than 30 countries and regions, especially in the European market that imposes extremely high requirements on product quality and performance. Edan provides fetal monitoring products and services to the largest medical group in Greece, IASO Children's Hospital; Centre Hospitalier Argenteuil Hospital, responsible for the health of nearly 0.3 million residents in central and northern France; and Iris Sud Brussels, the largest network center hospital in Belgium.

The iM3 series of vital sign monitors displayed this time, as well as the intelligent ward rounds and spot-check solutions formed by information technology solutions, have achieved massive access to internationally mainstream medical information systems, increasing market share year by year in regions such as the United States and Europe.

In the future, Edan will continue to firmly support the 'quality revolution' in response to the call for high-quality medical development, injecting strong power into the high-quality development of the health Silk Road, contributing to the construction of a new global health pattern, and achieving a win-win scenario.

About Edan
Edan, with a global perspective, continuous innovation, and excellent services, is an excellent provider of medical and health products, solutions, and services, covering six major business sectors, including patient monitoring, electrocardiogram diagnosis, ultrasound imaging, women's and children's health, in vitro diagnostics, and intelligent health. In China, Edan's service network, which radiates the national market, has provided innovative and high-quality products and services to more than 50,000 medical institutions. It has established four major research and development centers and 19 subsidiaries worldwide, with products sold in more than 170 countries and regions. Edan adheres to valuable innovations and is committed to providing high-quality products and solutions to medical institutions that meet clinical needs. Edan Instruments SHE:300206.